Cargando…

Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic

Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-García, Juan Carlos, Cortés-Martín, Jonathan, Rodríguez-Blanque, Raquel, Marín-Jiménez, Ana Eugenia, Montiel-Troya, Maria, Díaz-Rodríguez, Lourdes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003983/
https://www.ncbi.nlm.nih.gov/pubmed/33800980
http://dx.doi.org/10.3390/ijerph18063234
_version_ 1783671817869721600
author Sánchez-García, Juan Carlos
Cortés-Martín, Jonathan
Rodríguez-Blanque, Raquel
Marín-Jiménez, Ana Eugenia
Montiel-Troya, Maria
Díaz-Rodríguez, Lourdes
author_facet Sánchez-García, Juan Carlos
Cortés-Martín, Jonathan
Rodríguez-Blanque, Raquel
Marín-Jiménez, Ana Eugenia
Montiel-Troya, Maria
Díaz-Rodríguez, Lourdes
author_sort Sánchez-García, Juan Carlos
collection PubMed
description Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenced the lives of patients with rare diseases regarding depression and anxiety. This Spanish study considered a heterogeneous population sample of 86 patients with confirmed diagnosis of different rare diseases. Participants took part in a cross-sectional online study by completing specific questionnaires on the study topic. Depression was measured using the Patient Health Questionnaire (PHQ-9), and the General Anxiety Disorder Scale (GAD-7) was used for evaluating anxiety. Data collection through an online questionnaire allowed for a greater population scope and therefore the inclusion patients of other nationalities in the study sample. Finally, as a general result, this study found that, in the face of the pandemic, anxiety and depression remained at a higher level in this group than in the general population, making these patients a vulnerable population group.
format Online
Article
Text
id pubmed-8003983
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80039832021-03-28 Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic Sánchez-García, Juan Carlos Cortés-Martín, Jonathan Rodríguez-Blanque, Raquel Marín-Jiménez, Ana Eugenia Montiel-Troya, Maria Díaz-Rodríguez, Lourdes Int J Environ Res Public Health Article Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenced the lives of patients with rare diseases regarding depression and anxiety. This Spanish study considered a heterogeneous population sample of 86 patients with confirmed diagnosis of different rare diseases. Participants took part in a cross-sectional online study by completing specific questionnaires on the study topic. Depression was measured using the Patient Health Questionnaire (PHQ-9), and the General Anxiety Disorder Scale (GAD-7) was used for evaluating anxiety. Data collection through an online questionnaire allowed for a greater population scope and therefore the inclusion patients of other nationalities in the study sample. Finally, as a general result, this study found that, in the face of the pandemic, anxiety and depression remained at a higher level in this group than in the general population, making these patients a vulnerable population group. MDPI 2021-03-21 /pmc/articles/PMC8003983/ /pubmed/33800980 http://dx.doi.org/10.3390/ijerph18063234 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sánchez-García, Juan Carlos
Cortés-Martín, Jonathan
Rodríguez-Blanque, Raquel
Marín-Jiménez, Ana Eugenia
Montiel-Troya, Maria
Díaz-Rodríguez, Lourdes
Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic
title Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic
title_full Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic
title_fullStr Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic
title_full_unstemmed Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic
title_short Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic
title_sort depression and anxiety in patients with rare diseases during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003983/
https://www.ncbi.nlm.nih.gov/pubmed/33800980
http://dx.doi.org/10.3390/ijerph18063234
work_keys_str_mv AT sanchezgarciajuancarlos depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic
AT cortesmartinjonathan depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic
AT rodriguezblanqueraquel depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic
AT marinjimenezanaeugenia depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic
AT montieltroyamaria depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic
AT diazrodriguezlourdes depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic